Phase 3 Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman aged 18 or older at the time of agreeing to participate.
- You are able to understand the study information and agree to take part.
- You have been diagnosed with abnormal heavy bleeding from the uterus after giving birth (either vaginally or by C-section), suspected to be caused by the uterus not contracting properly, within 24 hours of delivery.
- Your estimated blood loss falls within a specific range: between 500–1,500 ml for a vaginal delivery, or between 1,000–1,500 ml for a C-section, measured at the time the study device is about to be used.
- Standard first-line treatments to stop the bleeding (medications to help the uterus contract and uterine massage) have already been tried but have not stopped the bleeding.
Who may not be able to join:
- Your estimated blood loss is more than 1,500 ml at the time the study device is about to be used.
- Your baby was born before 34 weeks of pregnancy.
- You had a C-section and your cervix was less than 3 cm open before the device would be used.
- Your doctor determines your bleeding requires more aggressive treatment, such as removal of the uterus, certain surgical stitching procedures, blocking or tying off specific blood vessels in the uterus or pelvis.
- You have a known abnormality in the shape or structure of your uterus.
- There is still an ongoing pregnancy in the uterus.
- You have a known problem with how the placenta attached or was delivered, including abnormal attachment, a retained placenta with known risk factors, or a retained placenta that cannot be easily removed by hand.
- You have a known tear or rupture of the uterus.
- You have an unresolved uterine inversion (where the uterus has turned inside out and has not been corrected).
- You have already received a balloon, packing, or another suction-based treatment inside the uterus for this episode of heavy bleeding before the study device would be used.
- You currently have cervical cancer.
- You currently have an active purulent (pus-forming) infection of the vagina, cervix, or uterus.
- You have been diagnosed with a blood clotting disorder.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Scott Chudnoff, MD, Maimonides Medical Center
Phone: 972-548106010
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of safety events; PPH control
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.